Deesomchok Athavudh, Liwsrisakun Chalerm, Chaiwong Warawut, Pothirat Chaicharn, Duangjit Pilaiporn, Bumroongkit Chaiwat, Theerakittikul Theerakorn, Limsukon Atikun, Tajarernmuang Pattraporn, Trongtrakul Konlawij, Niyatiwatchanchai Nutchanok
Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
Healthcare (Basel). 2023 Jul 7;11(13):1963. doi: 10.3390/healthcare11131963.
Many studies have demonstrated poor quality of life (QoL) at 3, 6, 12, and 24 months after coronavirus disease 2019 (COVID-19). However, these studies were limited due to cross-sectional design, a longer gap between visits, and lack of controls for comparison. Therefore, the aim of our prospective study was to assess the impact of COVID-19 pneumonia on QoL in both physical and mental health. A prospective study was conducted on adult patients with COVID-19 pneumonia. We used the 36-Item Short Form Health Survey (SF-36) and Euro Quality of Life-5 Dimensions-5 Levels (EQ-5D-5L), EQ visual analogue scale (EQ-VAS), and Hospital Anxiety and Depression Scale to collect data at months, 1, 3, 6, 9, and 12. Thirty-eight patients with COVID-19 pneumonia and twenty-five healthy subjects were completely followed up on all visits. All domains of SF-36, except bodily pain and EQ-5D-5L of the patients, were lower than controls. There was an improvement of EQ-VAS and SF-36 including physical functioning, social functioning, and role limitation (physical problems) domains throughout study period in the COVID-19 pneumonia group. Adult patients who recovered from COVID-19 pneumonia had lower QoL which improved over the one-year follow-up period.
许多研究表明，2019冠状病毒病（COVID-19）后3个月、6个月、12个月和24个月时患者的生活质量（QoL）较差。然而，这些研究存在局限性，包括横断面设计、访视间隔时间较长以及缺乏用于比较的对照组。因此，我们这项前瞻性研究的目的是评估COVID-19肺炎对身心健康方面生活质量的影响。对成年COVID-19肺炎患者进行了一项前瞻性研究。我们使用36项简短健康调查问卷（SF-36）、欧洲五维健康量表-5水平（EQ-5D-5L）、EQ视觉模拟量表（EQ-VAS）和医院焦虑抑郁量表在第1、3、6、9和12个月收集数据。38例COVID-19肺炎患者和25名健康受试者在所有访视中均得到了完整随访。患者的SF-36所有领域，除了身体疼痛和EQ-5D-5L，均低于对照组。在整个研究期间，COVID-19肺炎组的EQ-VAS以及SF-36的身体功能、社会功能和角色限制（身体问题）领域均有改善。从COVID-19肺炎中康复的成年患者生活质量较低，但在一年的随访期内有所改善。
